Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. BioNTech SE
  6. News
  7. Summary
    BNTX   US09075V1026

BIONTECH SE

(BNTX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

European ADRs Move Sharply Higher in Wednesday Trading

05/05/2021 | 11:05am EDT


ę MT Newswires 2021
All news about BIONTECH SE
12:59aSINOVAC BIOTECHá : BioNTech shots have stronger antibody response than Sinovac, ..
RE
06/18Foxconn chief, TSMC ready to negotiate for Taiwan's COVID-19 vaccines
AQ
06/18BIONTECHá : Israel to Deliver Soon-to-Expire COVID-19 Jabs to Palestine
MT
06/18EUROPEAN MIDDAY BRIEFINGá : Stocks Slip as -2-
DJ
06/18BioNTech Doses First Patient in Mid-Stage Study of mRNA Cancer Vaccine
MT
06/18BIONTECHá : Doses First Patient in Phase 2 Trial of Vaccine Candidate in Patient..
MT
06/18PRESS RELEASEá : BioNTech Announces First Patient Dosed in Phase 2 Clinical Tria..
DJ
06/18BioNTech Announces First Patient Dosed in Phase 2 Clinical Trial of mRNA-base..
GL
06/18BIONTECHá : Taiwan's Foxconn Seeks To Buy 5 Million Doses Of BioNTech's COVID-19..
MT
06/18CureVac COVID-19 Jab's Low Efficacy Said To Be Caused By Vaccine's Low Dosage
MT
More news
Financials
Sales 2021 12 387 M 14 690 M 14 690 M
Net income 2021 7 065 M 8 379 M 8 379 M
Net cash 2021 7 669 M 9 095 M 9 095 M
P/E ratio 2021 6,33x
Yield 2021 -
Capitalization 43 261 M 51 304 M 51 304 M
EV / Sales 2021 2,87x
EV / Sales 2022 2,80x
Nbr of Employees 2 200
Free-Float 87,3%
Chart BIONTECH SE
Duration : Period :
BioNTech SE Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BIONTECH SE
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 13
Average target price 147,88 €
Last Close Price 179,12 €
Spread / Highest target 10,9%
Spread / Average Target -17,4%
Spread / Lowest Target -49,0%
EPS Revisions
Managers and Directors
NameTitle
Ugur Sahin Chief Executive Officer
Sierk P÷tting Chief Operating & Financial Officer
Helmut Jeggle Chairman-Supervisory Board
Ízlem TŘreci Chief Medical Officer
Christoph Huber Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
BIONTECH SE160.57%51 304
GILEAD SCIENCES, INC.14.33%84 306
WUXI APPTEC CO., LTD.24.70%61 728
REGENERON PHARMACEUTICALS11.35%55 507
VERTEX PHARMACEUTICALS-20.52%48 760
BEIGENE, LTD.24.54%30 397